Moderna COVID-19 vaccine shows ‘no specific safety concerns’: US regulator

The US Food and Drug Administration (FDA) issues a positively worded briefing document about the Moderna COVID-19 vaccine ahead of a meeting by experts on whether to grant it emergency approval.

The FDA is upbeat on the vaccine, saying there are “no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization)” and confirms an overall efficacy of 94.1 percent.

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.